Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wedbush Downgrades Global Blood Therapeutics to Neutral

Wedbush Downgrades Global Blood Therapeutics to Neutral

Wedbush analyst Andreas Argyrides downgrades Global Blood Therapeutics (NASDAQ:GBT) from Outperform to Neutral.

August 8, 2022

1 minute read

Wedbush analyst Andreas Argyrides downgrades Global Blood Therapeutics (NASDAQ:GBT) from Outperform to Neutral.

What 7 Analyst Ratings Have To Say About Avery Dennison

January 19, 4:00 PM

During the last three months, 7 analysts shared their evaluations of Avery Dennison (NYSE:AVY), revealing diverse outlooks from…

February 16, 9:38 AM

https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/1160308/000119312524038108/d775782d8k.htm

July 19, 9:35 AM

Johnson & Johnson (NYSE: JNJ) shares are trading slightly higher Tuesday after the company announced better-than-expected financial results.

March 20, 8:09 AM

Within the last quarter, Signet Jewelers (NYSE:SIG) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…